期刊文献+

VEGF165真核表达载体的构建及其对白血病细胞增殖和化疗药物敏感性的影响 被引量:1

Construction of VEGF eukaryotic expression vector and its effects on proliferation and chemosensitivity in leukemia cells
下载PDF
导出
摘要 目的:构建血管内皮细胞生长因子的真核表达载体,探讨其对白血病细胞的增殖以及化疗药物敏感性的影响。方法:应用常规基因克隆方法构建pEGFP-C1-hVEGF165真核表达载体,转染白血病细胞K562,采用CCK8法检测重组质粒对细胞增殖的影响,RT-PCR方法检测细胞血管内皮细胞生长因子(VEGF)mRNA的表达水平,ELISA方法定量检测细胞培养液和细胞内VEGF蛋白的表达水平,用流式细胞仪检测细胞周期。结果:经酶切鉴定和基因测序证实成功构建了VEGF165真核表达载体。稳定转染pEGFP-C1-hVEGF165的K562细胞较转染pEGFP-C1空质粒的K562细胞增殖加快,VEGF165 mRNA表达明显增加,细胞分泌VEGF蛋白水平上调。转染pEGFP-C1-hVEGF165还可以提高白血病细胞在化疗药物高三尖杉酯碱和氟尿嘧啶作用时的细胞存活率。结论:VEGF165真核表达载体可以上调白血病细胞K562的VEGF mRNA和VEGF蛋白的表达水平,从而促进白血病细胞的增殖,同时可以降低白血病细胞对化疗药物高三尖杉酯碱和氟尿嘧啶的敏感性。 AIM: To investigate the effects of EPA and DHA on oxidative stress of lipopolysaccharide-stimulated rat mesangial cells. METHODS: The glomerular mesangial cells (GMCs) were stimulated by lipopolysaccharide (LPS) and incubated with EPA (10 μmol/L or 100 μmol/L) and DHA (10 μmol/L or 100 μmol/L) for 24 h, 48 h and 72 h. The activity of SOD, GSH-Px and the level of MDA was measured. The protein and mRNA expressions of MCP-1 and TGF-β1 were detected by immunocytochemistry and real-time PCR method, respectively. RESULTS: The activities of SOD and GSH-Px were decreased and the concentration of MDA was increased when stimulated with LPS. EPA and DHA increased the activities of SOD and GSH-Px and decreased the concentration of MDA significantly. Meanwhile, the protein and mRNA expressions of MCP-1 and TGF-β1 stimulated by LPS were decreased. DHA was more effective than EPA at the same concentration. CONCLUSION: EPA and DHA enhance the activities of antioxidant enzymes, decrease the concentration of MDA and inhibit the expression of TGF-β1 and MCP-1, suggesting that the protective effect of EPA and DHA on kidney is related to the antioxidation and the inhibition of TGF-β1 and MCP-1 expression.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第3期533-538,共6页 Chinese Journal of Pathophysiology
基金 广东省科技重点基金资助项目(No.2001-Z-037-01) 广东省自然科学基金资助项目(No.021195)
关键词 血管内皮细胞生长因子 真核表达载体 K562细胞 高三尖杉酯 氟尿嘧啶 Eicosapentaenoic acid Docosahexaenoic acid Mesangial cells Transforming growth factor beta Monocyte chemoattractant protein-1
  • 相关文献

参考文献9

  • 1范钰,张尤历,李华,许则丰,郑树.RNAi沉默Cripto基因对结肠癌细胞血管内皮生长因子的抑制[J].中国病理生理杂志,2008,24(2):242-245. 被引量:11
  • 2谢晓斌,龙捷,张绘宇,王红艳,徐若冰,李书华,张雅洁.VEGF-C在淋巴管生成及乳腺癌淋巴道转移中的作用[J].中国病理生理杂志,2008,24(4):650-654. 被引量:9
  • 3Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignances [ J ]. Cancer Res, 1999,59 (2) :728 - 733.
  • 4Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor [ J ]. J Biol Chem, 1991,266(18) :11947 - 11954.
  • 5Ghannadan M, Wimazal F, Simonitsch I, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category [ J ]. Am J Clin Pathol,2003,119 (5) :663 - 671.
  • 6Verstovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia [J]. Blood, 2002,99(6): 2265-2267.
  • 7Bairey O, Boycov O, Kaganovsky E, et al. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B -chronic lymphocytic leukemia (CLL) cells [ J ]. Leuk Res,2004,28 ( 3 ): 243 - 248.
  • 8Brown LF, Detmar M, Claffey K, et al. vascular permeability factor/ vascular endothelial growth factor: a multifunctional angiogenic cytokine [ J ]. EXS, 1997,79 : 233 - 269.
  • 9Bertolini F, Mancuso P, Gobbi A, et al. The thin red line: angiogenesis in normal and malignant hematopoiesis [J]. Exp Hematol, 2000,28(9) :993 - 1000.

二级参考文献23

  • 1李颖,范尔钟,胡承杰,于振坤.5′-核苷酸酶-碱性磷酸酶双重染色法在鉴别微淋巴管和微血管中的应用[J].中华病理学杂志,2004,33(3):290-291. 被引量:10
  • 2高大新,张海燕,杨向红,黄涛,王岩峰,吕刚.Survivin反义寡核苷酸对骨肉瘤细胞凋亡的诱导效应[J].中国病理生理杂志,2006,22(3):495-500. 被引量:4
  • 3范钰,郑树,丁佳逸.脂质体介导的cripto反义寡核苷酸抑制结肠癌细胞端粒酶活性[J].中国病理生理杂志,2006,22(4):762-765. 被引量:42
  • 4Arii S, Ishigami S, Mori A, et al. Implication of VEGF and MMPs in hepatic metastasis of human colon cancer [J]. Nippon Geka Gakkai Zasshi, 1998,99 (7) :436 - 440.
  • 5Widel MS, Widel M. Mechanisms of metastasis and molecular markers of malignant tumor progression. Ⅰ Colorectal cancer [ J ]. Postepy Hig Med Dosw, 2006,60 : 453 - 470.
  • 6Adamson ED, Minchiotti G, Salomon DS. Cripto: a tumor growth factor and more[ J]. J Cell Physiol,2002, 190(3) : 267 - 278.
  • 7Xing PX, Hu XF, Pietersz GA, et al. Cripto: a novel target for antibody- based cancer immunotherapy[ J]. Cancer Res, 2004,64( 11 ) :4018 -4023.
  • 8Normanno N, De Luca A, Salomon DS, et al. Epidermal growth factor- related peptides as targets for experimental therapy of human colon carcinoma [ J ]. Cancer Detect Prey, 1998,22( 1 ) :62 - 67.
  • 9De Angelis E, Grassi M, Gullick WJ, et al. Expression of Cripto and amphiregulin in colon mucosa from high risk colon cancer families[ J ]. Int J Oncol, 1999,14 (3) :437 -440.
  • 10Favier J,Plouin PF,Corvol P,et al. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors [ J ]. Am J Pathol, 2002, 161 (4) : 1235 - 1246.

共引文献18

同被引文献10

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 2徐叔云,魏伟.临床药理学[M].北京:人民卫生出版社,2006:213-214.
  • 3Long J, Parkin B, Ouillette P, et al. Multiple distinct mo- lecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia [ J ]. Blood, 2010,116:71 -80.
  • 4Kleinman ME, Yamada K, Takeda A, et al. Sequence-and target-independent angiogenesis suppression by siRNA via TLR3 [J]. Nature, 2008,452:591-597.
  • 5Bellamy WT, Richter L, Frutiger Y, et al. Expression of Vascular endothelial growth factor and its receptors in hema- topoietic malignances [ J ]. Cancer Res, 1999, 59 : 728 - 733.
  • 6Seftel MD, Demersb AA, Banerjia V, et al. High inci- dence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort [J]. Leuke Res, 2009, 33:1463 -1468.
  • 7Roswall N, Olsen A, Christensen J, et al. Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population- based study in Denmark, 1994 -2003 [J]. Eur J Cancer, 2008,44:2058 - 2073.
  • 8Fiedler W, Graeven U, Ergtin S, et al. Vascular endotheli- al growth factor, a possible paracrine growth factor in hu- man acute myeloid leukemia [ J ]. Blood, 1997, 89 : 1870 - 1875.
  • 9Aguayo A, Kantarjian H, Manshouri T, et al. Angiogene- sis in acute and chronic leukemias and myelodysplastic syndromes [ J]. Blood, 2000, 96:2240 - 2245.
  • 10王吉耀.内科学[M].北京:人民卫生出版社,2006:575—580.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部